BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 26248315)

  • 1. SPARC Controls Melanoma Cell Plasticity through Rac1.
    Salvatierra E; Alvarez MJ; Leishman CC; Rivas Baquero E; Lutzky VP; Chuluyan HE; Podhajcer OL
    PLoS One; 2015; 10(8):e0134714. PubMed ID: 26248315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SPARC functions as an anti-stress factor by inactivating p53 through Akt-mediated MDM2 phosphorylation to promote melanoma cell survival.
    Fenouille N; Puissant A; Tichet M; Zimniak G; Abbe P; Mallavialle A; Rocchi S; Ortonne JP; Deckert M; Ballotti R; Tartare-Deckert S
    Oncogene; 2011 Dec; 30(49):4887-900. PubMed ID: 21685937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SPARC-induced migration of glioblastoma cell lines via uPA-uPAR signaling and activation of small GTPase RhoA.
    Kunigal S; Gondi CS; Gujrati M; Lakka SS; Dinh DH; Olivero WC; Rao JS
    Int J Oncol; 2006 Dec; 29(6):1349-57. PubMed ID: 17088972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SPARC promotes cathepsin B-mediated melanoma invasiveness through a collagen I/α2β1 integrin axis.
    Girotti MR; Fernández M; López JA; Camafeita E; Fernández EA; Albar JP; Benedetti LG; Valacco MP; Brekken RA; Podhajcer OL; Llera AS
    J Invest Dermatol; 2011 Dec; 131(12):2438-47. PubMed ID: 21850018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SPARC modulates the proliferation of stromal but not melanoma cells unless endogenous SPARC expression is downregulated.
    Haber CL; Gottifredi V; Llera AS; Salvatierra E; Prada F; Alonso L; Sage EH; Podhajcer OL
    Int J Cancer; 2008 Apr; 122(7):1465-75. PubMed ID: 18059024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SPARC mediates Src-induced disruption of actin cytoskeleton via inactivation of small GTPases Rho-Rac-Cdc42.
    Bhoopathi P; Gondi CS; Gujrati M; Dinh DH; Lakka SS
    Cell Signal; 2011 Dec; 23(12):1978-87. PubMed ID: 21798346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Secreted Protein Acidic and Rich in Cysteine (SPARC) Enhances Cell Proliferation, Migration, and Epithelial Mesenchymal Transition, and SPARC Expression is Associated with Tumor Grade in Head and Neck Cancer.
    Chang CH; Yen MC; Liao SH; Hsu YL; Lai CS; Chang KP; Hsu YL
    Int J Mol Sci; 2017 Jul; 18(7):. PubMed ID: 28718842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The p53/p21Cip1/ Waf1 pathway mediates the effects of SPARC on melanoma cell cycle progression.
    Fenouille N; Robert G; Tichet M; Puissant A; Dufies M; Rocchi S; Ortonne JP; Deckert M; Ballotti R; Tartare-Deckert S
    Pigment Cell Melanoma Res; 2011 Feb; 24(1):219-32. PubMed ID: 20955243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Secreted protein acidic and rich in cysteine (SPARC) inhibits integrin-mediated adhesion and growth factor-dependent survival signaling in ovarian cancer.
    Said N; Najwer I; Motamed K
    Am J Pathol; 2007 Mar; 170(3):1054-63. PubMed ID: 17322388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SPARC represses E-cadherin and induces mesenchymal transition during melanoma development.
    Robert G; Gaggioli C; Bailet O; Chavey C; Abbe P; Aberdam E; Sabatié E; Cano A; Garcia de Herreros A; Ballotti R; Tartare-Deckert S
    Cancer Res; 2006 Aug; 66(15):7516-23. PubMed ID: 16885349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SPARC endogenous level, rather than fibroblast-produced SPARC or stroma reorganization induced by SPARC, is responsible for melanoma cell growth.
    Prada F; Benedetti LG; Bravo AI; Alvarez MJ; Carbone C; Podhajcer OL
    J Invest Dermatol; 2007 Nov; 127(11):2618-28. PubMed ID: 17625595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Secreted protein acidic and rich in cysteine antagonizes bufalin-induced apoptosis in gastric cancer cells.
    Li A; Qu X; Li Z; Qu J; Song N; Ma Y; Liu Y
    Mol Med Rep; 2015 Aug; 12(2):2926-32. PubMed ID: 25936899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteolytic Isoforms of SPARC Induce Adipose Stromal Cell Mobilization in Obesity.
    Tseng C; Kolonin MG
    Stem Cells; 2016 Jan; 34(1):174-90. PubMed ID: 26381424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteomic analysis identified N-cadherin, clusterin, and HSP27 as mediators of SPARC (secreted protein, acidic and rich in cysteines) activity in melanoma cells.
    Sosa MS; Girotti MR; Salvatierra E; Prada F; de Olmo JA; Gallango SJ; Albar JP; Podhajcer OL; Llera AS
    Proteomics; 2007 Nov; 7(22):4123-34. PubMed ID: 17994631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unraveling mysteries of the multifunctional protein SPARC.
    Fukunaga-Kalabis M; Herlyn M
    J Invest Dermatol; 2007 Nov; 127(11):2497-8. PubMed ID: 17934501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ILK mediates actin filament rearrangements and cell migration and invasion through PI3K/Akt/Rac1 signaling.
    Qian Y; Zhong X; Flynn DC; Zheng JZ; Qiao M; Wu C; Dedhar S; Shi X; Jiang BH
    Oncogene; 2005 Apr; 24(19):3154-65. PubMed ID: 15735674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitory effect of capsaicin on B16-F10 melanoma cell migration via the phosphatidylinositol 3-kinase/Akt/Rac1 signal pathway.
    Shin DH; Kim OH; Jun HS; Kang MK
    Exp Mol Med; 2008 Oct; 40(5):486-94. PubMed ID: 18985006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 14-3-3beta-Rac1-p21 activated kinase signaling regulates Akt1-mediated cytoskeletal organization, lamellipodia formation and fibronectin matrix assembly.
    Somanath PR; Byzova TV
    J Cell Physiol; 2009 Feb; 218(2):394-404. PubMed ID: 18853424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autocrine control of glioma cells adhesion and migration through IRE1α-mediated cleavage of SPARC mRNA.
    Dejeans N; Pluquet O; Lhomond S; Grise F; Bouchecareilh M; Juin A; Meynard-Cadars M; Bidaud-Meynard A; Gentil C; Moreau V; Saltel F; Chevet E
    J Cell Sci; 2012 Sep; 125(Pt 18):4278-87. PubMed ID: 22718352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Snail promotes cell migration through PI3K/AKT-dependent Rac1 activation as well as PI3K/AKT-independent pathways during prostate cancer progression.
    Henderson V; Smith B; Burton LJ; Randle D; Morris M; Odero-Marah VA
    Cell Adh Migr; 2015; 9(4):255-64. PubMed ID: 26207671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.